CRC Tier 1 - Tools and resources for systematically discovering clinically-relevant biomarkers of cancer

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Pathology Hematology and hematologic malignancies

Fred R Hirsch

Squamous Cell Carcinoma of the Lung: Validation of Molecular Signatures for Prognosis

Trachea, bronchus and lung

Pathology

Andrew Weng

Adult vs. Fetal Programs in Leukemia Pathogenesis

Leukaemia

Pathology Pediatric oncology or childhood cancer

Mirlinda Kachuri

Comprehensive investigation of telomere length and its genetic determinants in cancer risk and clinical outcomes

Nasopharynx Lip, oral cavity Larynx Other pharynx Trachea, bronchus and lung Pancreas Oesophagus

Roanne Leigh Thomas

CRC Tier 2 - Implications of chronic illness and disability for marginalized populations

Melanoma of skin

Alberto Cambrosio

Genomic medicine enters the clinic: translational research, actionable mutations, clinical utility, and the reframing of oncology

Melanoma of skin

Avrum E Spira

Molecular Biomarkers of Airway and Lung Linking COPD and Lung Cancer

Trachea, bronchus and lung

Pathology

Mary Anne Rossing

Epidemiologic Factors and Survival by Molecular Subtypes of Ovarian Cancer

Ovary

Pathology

Aimee L Edinger

Identification of the Anti-Neoplastic Target of Bioactive FTY720 Analogs

Leukaemia